Welcome to PsychU!

Virtual Event – Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics

Loading Events

Thank You For Attending Today’s Webinar

Please tell us what you thought about today’s presentation by taking the survey below:

Virtual Event – Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics

This is a National Virtual Event for all PsychU members.

In “Strategies to Optimize Patient Outcomes in Bipolar I Disorder: the Role of Long-Acting Injectable Antipsychotics,” the objectives of this presentation are to understand the impact of mood episode recurrence in bipolar I disorder on patient functioning and clinical outcomes, discuss risk factors for mood episode recurrence, including nonadherence, in patients with bipolar I disorder, and review management strategies, including long-acting injectable antipsychotics (LAIs), to optimize patient outcomes in bipolar I disorder.

Featuring

Martin-Guerrero

Martin Guerrero, MD, JD

Forensic and Geriatric Psychiatrist, El Paso, Texas

Jessie-Chambers

Jessie Chambers, PhD (OPDC)

Sr. Clinical & Scientific Liaison

Speaker Martin Guerrero, MD, JD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc.
Speaker Jessie Chambers, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Related Resources